Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-Label Long-Term Pregabalin Study for Central Neuropathic Pain
jRCT2080221298Phase 3
- Sponsor
- Pfizer
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of pregabalin in central neuropathic pain (CNP), central poststroke pain (CPSP) and central neuropathic pain in multiple sclerosis (2 arms), sponsored by Pfizer.
02
Drugs
pregabalin
03
Conditions
central neuropathic pain (CNP)central poststroke pain (CPSP)central neuropathic pain in multiple sclerosis
Beyond the preview
Go deeper on jRCT2080221298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221298.